JP4982757B2 - ｈＴＥＲＴ発現調節遺伝子 - Google Patents

ｈＴＥＲＴ発現調節遺伝子 Download PDF

Info

Publication number
JP4982757B2
JP4982757B2 JP2007521154A JP2007521154A JP4982757B2 JP 4982757 B2 JP4982757 B2 JP 4982757B2 JP 2007521154 A JP2007521154 A JP 2007521154A JP 2007521154 A JP2007521154 A JP 2007521154A JP 4982757 B2 JP4982757 B2 JP 4982757B2
Authority
JP
Japan
Prior art keywords
gene
expression
rna
base sequence
htert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2007521154A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2006112239A1 (ja
Inventor
典正 三浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tottori University NUC
Original Assignee
Tottori University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tottori University NUC filed Critical Tottori University NUC
Priority to JP2007521154A priority Critical patent/JP4982757B2/ja
Publication of JPWO2006112239A1 publication Critical patent/JPWO2006112239A1/ja
Application granted granted Critical
Publication of JP4982757B2 publication Critical patent/JP4982757B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007521154A 2005-04-15 2006-03-28 ｈＴＥＲＴ発現調節遺伝子 Expired - Lifetime JP4982757B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007521154A JP4982757B2 (ja) 2005-04-15 2006-03-28 ｈＴＥＲＴ発現調節遺伝子

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005118364 2005-04-15
JP2005118364 2005-04-15
JP2007521154A JP4982757B2 (ja) 2005-04-15 2006-03-28 ｈＴＥＲＴ発現調節遺伝子
PCT/JP2006/306338 WO2006112239A1 (ja) 2005-04-15 2006-03-28 ｈＴＥＲＴ発現調節遺伝子

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011263124A Division JP5240632B2 (ja) 2005-04-15 2011-11-30 ｈＴＥＲＴ発現調節遺伝子

Publications (2)

Publication Number Publication Date
JPWO2006112239A1 JPWO2006112239A1 (ja) 2008-12-11
JP4982757B2 true JP4982757B2 (ja) 2012-07-25

Family

ID=37114970

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007521154A Expired - Lifetime JP4982757B2 (ja) 2005-04-15 2006-03-28 ｈＴＥＲＴ発現調節遺伝子
JP2011263124A Expired - Fee Related JP5240632B2 (ja) 2005-04-15 2011-11-30 ｈＴＥＲＴ発現調節遺伝子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011263124A Expired - Fee Related JP5240632B2 (ja) 2005-04-15 2011-11-30 ｈＴＥＲＴ発現調節遺伝子

Country Status (4)

Country Link
US (4) US7985852B2 (https=)
EP (2) EP1873240B1 (https=)
JP (2) JP4982757B2 (https=)
WO (1) WO2006112239A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5781732B2 (ja) * 2010-01-13 2015-09-24 国立大学法人鳥取大学 がん抑制ｍｉＲＮＡ
CN103189511B (zh) * 2010-07-12 2016-10-12 国立大学法人鸟取大学 利用siRNA导入的新型hiPSC制作法
JPWO2015030149A1 (ja) * 2013-08-29 2017-03-02 国立大学法人鳥取大学 細胞のアンチエイジングに関連する生体分子群
JP7465656B2 (ja) * 2019-12-25 2024-04-11 株式会社Ｕａｃｊ製箔 グラビア印刷版

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
PT1309726E (pt) * 2000-03-30 2010-03-08 Whitehead Biomedical Inst Mediadores de interferência por rna específicos de sequência de rna
JP2002104995A (ja) 2000-09-29 2002-04-10 Masahiko Hosaka テロメラーゼ活性抑制剤
US20050227936A1 (en) * 2001-05-18 2005-10-13 Sirna Therapeutics, Inc. RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
US20030099616A1 (en) 2001-07-25 2003-05-29 Irving John M. Dual specificity tumor killing vectors driven by the telomerase promoter
GB0130955D0 (en) * 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
AU2003207708A1 (en) * 2002-02-20 2003-09-09 Sirna Therapeutics, Inc. Rna interference mediated inhibition of map kinase genes
EP2305812A3 (en) * 2002-11-14 2012-06-06 Dharmacon, Inc. Fuctional and hyperfunctional sirna
EP1571209B1 (en) 2002-11-22 2012-06-13 Bio-Think Tank Co., Ltd. Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence
ES2356910T3 (es) * 2003-01-17 2011-04-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Construcciones para la expresión inducible de arn de interferencia pequeño (arns) para el silenciamiento génico seleccionado.
JP2004350607A (ja) 2003-05-30 2004-12-16 Dai Ichi Seiyaku Co Ltd テロメレース阻害剤

Also Published As

Publication number Publication date
EP1873240A4 (en) 2008-09-10
US20100248356A1 (en) 2010-09-30
JP5240632B2 (ja) 2013-07-17
EP1873240A1 (en) 2008-01-02
US20100184208A1 (en) 2010-07-22
JPWO2006112239A1 (ja) 2008-12-11
US7985852B2 (en) 2011-07-26
US20100184216A1 (en) 2010-07-22
US20090124794A1 (en) 2009-05-14
EP2098593B1 (en) 2011-12-28
US8148514B2 (en) 2012-04-03
EP1873240B1 (en) 2011-12-28
JP2012085645A (ja) 2012-05-10
US8148513B2 (en) 2012-04-03
WO2006112239A1 (ja) 2006-10-26
US8124755B2 (en) 2012-02-28
EP2098593A1 (en) 2009-09-09

Similar Documents

Publication Publication Date Title
Bingle et al. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death
Szymanski et al. A new frontier for molecular medicine: noncoding RNAs
Guerardel et al. Identification in the human candidate tumor suppressor geneHIC-1 of a new major alternative TATA-less promoter positively regulated by p53
WO2004065613A2 (en) Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
WO2010006239A2 (en) Regulation of apoptosis by neural specific splice variants of ig20
JP5240632B2 (ja) ｈＴＥＲＴ発現調節遺伝子
Medina et al. Tissue-specific N-terminal isoforms from overlapping alternate promoters of the human AE2 anion exchanger gene
Tanwar et al. MITF is a novel transcriptional regulator of the calcium sensor STIM1: Significance in physiological melanogenesis
CN107541513A (zh) 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用
US20060079471A1 (en) Snornai-small nucleolar rna degradation by rna interference in trypanosomatids
CN108342365B (zh) 一种用于治疗癌症的慢病毒及其制备方法应用
Ng et al. Isolation and characterization of a novel TP53‐inducible gene, TP53TG3
JP2007530431A (ja) 膵臓癌を治療するための組成物および方法
Kasukabe et al. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines
CN106350519A (zh) 一种调节鹿茸软骨快速生长的microRNA及其应用
CN106244593A (zh) 一种调节鹿茸茸皮快速生长的microRNA及其应用
CN108339126B (zh) 一种用于治疗癌症的基因靶向药物及其应用
JP6366415B2 (ja) Ｏｒａｉ３遺伝子発現抑制剤又はＯＲＡＩ３タンパク質の機能抑制剤を含む細胞賦活剤
Spirin et al. Modulation of activated oncogene c-kit expression with RNA-interference
JP7153033B2 (ja) 真核生物におけるｒｎａ分子の細胞型特異的な翻訳に関する系及び方法
CN108338986B (zh) 一种用于治疗癌症的小分子rna及其应用
CN113227375A (zh) 合成的微小rna模拟物
JP2004519216A (ja) 進行によって抑制される遺伝子１３（ＰＳＧｅｎ１３）およびその使用
Rashvand et al. Induction of Apoptosis and Growth Suppression by Homeobox Gene TGIFLX in Prostate Cancer Cell Line Lncap
CN108342415B (zh) 一种用于治疗癌症的慢病毒质粒及其应用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090317

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090902

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090911

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20100713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120321

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150